Microbot Medical (MBOT) filed a registration statement Tuesday for the issuance of 3.2 million common shares if the selling stockholders exercise their preferred investment options.
If the selling stockholders sell the securities, Microbot will not receive any proceeds from such sale, but the company may receive about $4.85 million in proceeds if all of the preferred investment options are exercised.
Proceeds, if any, will be allocated to working capital, the company said.
Price: 1.07, Change: -0.03, Percent Change: -2.73
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments